Menu Search
Equities

Modulight Oyj

MODU:HEX

Modulight Oyj

Actions
Health CareMedical Equipment and Services
  • Price (EUR)1.00
  • Today's Change0.145 / 16.96%
  • Shares traded174.87k
  • 1 Year change-15.54%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy2
Outperform0
Hold0
Sell1
Strong Sell0

Share price forecast in EUR

The 3 analysts offering 12 month price targets for Modulight Oyj have a median target of 1.70, with a high estimate of 1.80 and a low estimate of 0.90. The median estimate represents a 70.00% increase from the last price of 1.00.
High80.0%1.80
Med70.0%1.70
Low-10.0%0.90

Earnings history & estimates in EUR

On Oct 18, 2024, Modulight Oyj reported 3rd quarter 2024 losses of -0.05 per share. This result was in line with the consensus of the 2 analysts following the company and exceeded last year's 3rd quarter results by 28.57%.
The next earnings announcement is expected on Feb 24, 2025.
Average growth rate-7.44%
Modulight Oyj reported annual 2023 losses of -0.28 per share on Feb 23, 2024.
Average growth rate-40.00%
More ▼

Revenue history & estimates in EUR

Modulight Oyj had 3rd quarter 2024 revenues of 640.00k. This missed the 1.25m consensus estimate of the 2 analysts following the company. This was 57.13% below the prior year's 3rd quarter results.
Average growth rate+28.09%
Modulight Oyj had revenues for the full year 2023 of 4.03m. This was 12.48% below the prior year's results.
Average growth rate-12.48%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.